Findings on non-small cell lung cancer (NSCLC) reveal that JADE2’s heightened expression correlates with improved 5-year survival rates, underscoring its role in tumorigenesis (Murphy et al., 2023). The gene discussed is JADE2; the disease is non-small cell lung carcinoma.